Stock listing
Uniqure N.v.
- Ticker
- BOATS:QURE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
About Uniqure N.v.
Uniqure N.V. is a public company traded on the American market under the ticker QURE. The company is committed to advancing innovative treatment options to improve patient outcomes.
Latest news from Uniqure N.v.
UniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
Sep 29, 2026
UniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
Sep 2, 2026
UniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
Jul 29, 2026
UniQure to Announce Second Quarter 2026 Financial Results
Jul 22, 2026